Following Israel, Canadian Medtech Firms Seek Collaboration in Beijing

Canadian Delegation and Chinese Representatives Attending the Conference

VCBeat News reported that the “China-Canada Healthcare Enterprise Exchange Meeting,” co-hosted by the Canadian Embassy in China and Health Valley, was successfully held at Beijing Health Valley on March 23.

This conference attracted numerous Chinese institutions and healthcare companies, includingJinshi Investment, Hanhai Capital, Qingke Tongrun, Ruide Medical Group, Hong Kong Pangu Technology, and other investment institutions and enterprises.

Eight cutting-edge healthcare companies from Canada participated, including firms specializing in medical devices, disease diagnosis, and cancer screening.

Jin Bi, Deputy General Manager of Health Intelligence Valley, delivered a welcome address on stage.

According to VCBeat, the conference aims to foster partnerships between cutting-edge medical enterprises in China and Canada, establishing a “green channel” for Sino-Canadian healthcare companies through capital and industrial collaboration.

Ajuvia Life Sciences / Perspectis Inc.

Intelligent Neuromechanical Medical Devices (Pillows, Cushions, Wearable Devices): Leveraging proprioceptive stimulation to improve users' spinal health and alleviate back pain. R&D Advantages: Development of intelligent medical devices (mHealth)

Fusion Genomics Corp.

Developing infectious disease diagnostic products using next-generation sequencing technology. The company has currently developed three diagnostic products for 1) seasonal influenza surveillance, 2) environmental monitoring of avian influenza, and 3) precise genotyping of the hepatitis C virus.

Halifax Biomedical Inc. 

Ultra-high-precision stereoscopic X-ray technology for assessing implant micromotion stability and spinal instability; in vivo real-time laser spectroscopy. Capable of assisting surgeons in making better-informed decisions on preoperative, intraoperative, and postoperative treatment plans.

Metabolomic Technologies Inc.

It is a novel urine-based diagnostic test grounded in advanced metabolomics for screening adenomatous polyps, the precursors to colorectal cancer. Early screening and removal of colonic polyps can effectively prevent the development of colorectal cancer.

Molecular You Corporation

Provides a digital platform for comprehensive analysis of the physical and clinical characteristics of genetics, blood proteins, metabolites, and gut microbiome profiles

NTBIO DIAGNOSTICS INC.

Specialized development of rapid testing and point-of-care diagnostic systems (immunoassays) for a wide range of fields, including infectious diseases, oncology, cardiac abnormalities, sepsis, substance abuse, food safety, veterinary diseases, and prenatal screening.

Rehabtronics Inc.

Developed three neurorehabilitation medical devices for upper limb rehabilitation following significant neurological injury or disease (e.g., stroke, spinal cord injury, traumatic brain injury, etc.).

Response Bio

Runbang Biomedical Co., Ltd. was established in 1992, with its headquarters located in beautiful Vancouver. Its product line, RUIPU, belongs to the category of point-of-care testing (POCT) products for in vitro diagnostics. The research and development, as well as the manufacturing of both instruments and reagents, are entirely conducted in Vancouver, with products distributed globally. The portfolio includes two instrument models and four major product categories: clinical cardiac markers, infectious diseases, biodefense, and environmental monitoring. Currently, the products sold in China are cardiac markers and biodefense products.

Health Intelligence Valley is China’s first industrial park brand themed around “Big Health.” Leveraging Tianyi Group’s strong capital strength as a leading enterprise and industrial investor in the healthcare sector, along with Meinian Onehealth Healthcare Group’s extensive customer base, health big data, and offline medical service platforms, Health Intelligence Valley has built a “professional healthcare industry ecosystem” that integrates health industry clustering, incubation, investment, health management, and service platforms.

Canadian Delegation Visits Health Intelligence Valley

VCBeat has learned that at this China-Israel corporate exchange event, Health Intelligence Valley continued to serve as a matchmaking platform, with the key difference being that the parties being connected were medical enterprise representatives from one country to another. It is believed that in the future, thanks to the continuous efforts of medical industry docking platforms like Health Intelligence Valley, more Chinese capital will enter the Canadian market, while Chinese medical enterprises will also gain more opportunities for learning and exchange.